English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduPsilocybin – the active ingredient in psychedelic mushrooms – shows promise for the transitional treatment of episodic migraines in early clinical trials, according to a review from Yale School of Medicine’s Emmanuelle Schindler, M.D., Ph.D. In the first and only…
Tag: psychedelic drugs
Study Shows Psychedelic Drugs Reopen ‘Critical Periods’ for Social Learning
Neuroscientists have long searched for ways to reopen “critical periods” in the brain, when mammals are more sensitive to signals from their surroundings that can influence periods of brain development. Now, researchers at Johns Hopkins Medicine say a new study in mice shows that psychedelic drugs are linked by their common ability to reopen such critical periods, but differ in the length of time the critical period is open — from two days to four weeks with a single dose.
Mystical and insightful psychedelic experience may improve mental health
A more mystical and insightful psychedelic drug experience may be linked to an enduring reduction in anxiety and depression symptoms, according to a new study.
Expert Q&A: Psychedelic Drugs and Mental Health
California’s attorney general recently approved signature gathering for a proposed ballot initiative that seeks to decriminalize psilocybin, the active ingredient in so-called “magic mushrooms,” and to authorize research into the medical use of the compound.
Psychedelic Science Holds Promise for Mainstream Medicine
A team of UNLV neuroscientists are uncovering how psychedelics affect brain activity. Their work, published recently in Nature: Scientific Reports, shows a strong connection in rodent models between brain activity and behaviors resulting from psychedelic treatment, a step forward in the quest to better understand their potential therapeutic effects.